Golden Ally Lifetech Group, Inc.
AQPW · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $40 | $0 | $0 | $0 |
| Gross Profit | -$40 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $98 | $0 | $0 | $0 |
| G&A Expenses | $4,215 | $189 | $355 | $114 |
| SG&A Expenses | $5,973 | $189 | $355 | $114 |
| Sales & Mktg Exp. | $1,758 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $6,072 | $189 | $355 | $114 |
| Operating Income | -$6,072 | -$189 | -$355 | -$114 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $131 | $0 | -$1 |
| Pre-Tax Income | -$6,072 | -$58 | -$355 | -$115 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6,072 | -$58 | -$355 | -$115 |
| % Margin | – | – | – | – |
| EPS | -0.072 | -0.002 | -0.019 | -0.009 |
| % Growth | -3,872.2% | 90.3% | -115.1% | – |
| EPS Diluted | -0.072 | -0.002 | -0.019 | -0.009 |
| Weighted Avg Shares Out | 84,906 | 94,800 | 19,157 | 13,386 |
| Weighted Avg Shares Out Dil | 84,906 | 94,800 | 19,157 | 13,386 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $40 | $237 | $0 | $1 |
| EBITDA | -$6,031 | $179 | -$355 | -$113 |
| % Margin | – | – | – | – |